Extracellular signal-regulated kinases (ERKs) play crucial roles in hepatic glucose and lipid metabolisms, in line with when ERK1 knockout mice displayed excess of weight and insulin resistance, besides liver-specific ERK2-knockout mice presenting also hepatic steatosis, glucose intolerance and reduced insulin sensitivity [9,10]. This evidence concerns the gene MAPK3 and Glucose intolerance.